Roxithromycin (BioDeep_00000230939)

   

natural product Chemicals and Drugs


代谢物信息卡片


(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-{O-[(2-methoxyethoxy)methyl]oxime} (non-preferred name)

化学式: C41H76N2O15 (836.5245426)
中文名称: 罗红霉素
谱图信息: 最多检出来源 Chinese Herbal Medicine(otcml) 7.32%

分子结构信息

SMILES: C(OC(O3)CC(OC)(C(O)C(C)3)C)(C1C)C(C(OC(CC)C(C(C(C(C(C)CC(C1OC(C2O)OC(C)CC2N(C)C)(C)O)=NOCOCCOC)C)O)(C)O)=O)C
InChI: InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1

描述信息

Semisynthetic derivative of erythromycin A.
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FA - Macrolides
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
A minor geometrical isomer of roxithromycin.
Roxithromycin is semisynthetic derivative of erythromycin A. It has a role as an antibacterial drug. It is an erythromycin derivative, a macrolide and a semisynthetic derivative. It is functionally related to an erythromycin A.
Roxithromycin is a semi-synthethic macrolide antibiotic that is structurally and pharmacologically similar to [erythromycin], [azithromycin], or [clarithromycin]. It was shown to be more effective against certain Gram-negative bacteria, particularly Legionella pneumophila. Roxithromycin exerts its antibacterial action by binding to the bacterial ribosome and interfering with bacterial protein synthesis. It is marketed in Australia as a treatment for respiratory tract, urinary and soft tissue infections.
Roxithromycin is a semi-synthetic derivative of the macrolide antibiotic erythromycin that includes an N-oxime side chain on the lactone ring, with antibacterial and anti-malarial activities. Roxithromycin binds to the subunit 50S of the bacterial ribosome, which inhibits bacterial protein synthesis and leads to inhibition of bacterial cell growth and replication.
Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.
C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic
C254 - Anti-Infective Agent > C258 - Antibiotic
CONFIDENCE standard compound; INTERNAL_ID 409; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8421; ORIGINAL_PRECURSOR_SCAN_NO 8419
CONFIDENCE standard compound; INTERNAL_ID 409; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8435; ORIGINAL_PRECURSOR_SCAN_NO 8434
CONFIDENCE standard compound; INTERNAL_ID 409; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8464; ORIGINAL_PRECURSOR_SCAN_NO 8462
CONFIDENCE standard compound; INTERNAL_ID 409; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8460; ORIGINAL_PRECURSOR_SCAN_NO 8458
CONFIDENCE standard compound; INTERNAL_ID 409; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8482; ORIGINAL_PRECURSOR_SCAN_NO 8478
CONFIDENCE standard compound; INTERNAL_ID 409; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8375; ORIGINAL_PRECURSOR_SCAN_NO 8373
CONFIDENCE standard compound; INTERNAL_ID 2185
CONFIDENCE standard compound; INTERNAL_ID 4097

同义名列表

76 个代谢物同义名

Roxithromycin; Ccris 3461; (Z)-roxithromycin; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-{O-[(2-methoxyethoxy)methyl]oxime} (non-preferred name); (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2-methoxyethoxy)methoxy]imino}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)methoxy)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-4-((2,6DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-14-ETHYL-7,12,13-TRIHYDROXY-10-((E)((2-METHOXYETHOXY)METHOXY)IMINO)-3,5,7,9,11,13HEXAMETHYL-6-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLOHEXOPYRANOSYL)OXY)OXACYCLOTETRADECAN-2-ONE; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-10-{[(2-methoxyethoxy)methoxy]imino}-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-10-{[(2-methoxyethoxy)methoxy]imino}-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2-methoxyethoxy)m; Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime), (9E)-; 9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin, (9E)-; (9E)-erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); ERYTHROMYCIN 9-(E)-(O-((2-METHOXYETHOXY)METHYL)OXIME); (E)-ERYTHROMYCIN-9-(O-((2-METHOXYETHOXY)METHYL)OXIME); 9-[O-(2-methoxyethoxymethyl)-oxime] of erythromycin; ERYTHROMYCIN A, 9-(O-(2-METHOXYETHOXYMETHYL)-OXIME); Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime); Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); Erythromycin 9-[O-[(2-methoxyethoxy)methyl]oxime]; 9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin; 9-(O-((2-Methoxyethoxy)methyl)oxime)erythromycin; Roxithromycin [USAN:INN:BAN:JAN]; Roxithromycin (JP17/USAN/INN); ROXITHROMYCIN [EP MONOGRAPH]; ROXITHROMYCIN [EP IMPURITY]; Roxitromicina [Spanish]; Roxithromycinum [Latin]; Roxithromycine [French]; ROXITHROMYCIN [WHO-DD]; ROXITHROMYCIN [MART.]; ROXITHROMYCIN [USAN]; ROXITHROMYCIN [JAN]; Roxi-paed 1A Pharma; ROXITHROMYCIN [INN]; ROXITHROMYCIN [MI]; (E)-roxithromycin; Roxithromycin,(S); MTW-Roxithromycin; Spectrum5_001058; UNII-21KOF230FA; Roxithromycinum; Roxithromycine; Roxi 1A Pharma; Roxitromicina; Roxithro-Lich; Tox21_301835; Tox21_113150; Tox21_110697; Infectoroxit; Rulide (TN); IDI1_000382; Roxi Basics; roxi von ct; Roxi-Wolff; 21KOF230FA; Roxi-Puren; Roxi-saar; Roxigamma; Roxihexal; Rotramin; Roxigrün; Roxibeta; Macrosil; Roxi TAD; roxidura; Claramid; Rotesan; Biaxsig; Rulide; Roxi-Q; Rulid; Roxithromycin (Roxl-150)



数据库引用编号

40 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Jiahua Guo, Yi Bai, Zhi Chen, Jiezhang Mo, Qi Li, Haotian Sun, Qiang Zhang. Transcriptomic analysis suggests the inhibition of DNA damage repair in green alga Raphidocelis subcapitata exposed to roxithromycin. Ecotoxicology and environmental safety. 2020 Sep; 201(?):110737. doi: 10.1016/j.ecoenv.2020.110737. [PMID: 32505758]
  • Abdelghani Mahmoudi, Mihaela Tertiş, Laura-Mihaela Simon, Ann Van Schepdael, Silvia De Francia, Lia-Monica Junie, Robert Săndulescu. Correlated quantification using microbiological and electrochemical assays for roxithromycin determination in biological and pharmaceutical samples. Talanta. 2020 May; 211(?):120703. doi: 10.1016/j.talanta.2019.120703. [PMID: 32070606]
  • Xiang Liu, Chen Chen, Xiaoying Zhang. Drug-drug interaction of acetaminophen and roxithromycin with the cocktail of cytochrome P450 and hepatotoxicity in rats. International journal of medical sciences. 2020; 17(3):414-421. doi: 10.7150/ijms.38527. [PMID: 32132876]
  • X F Gu, X M Chen, H J Chen, T T Xu, Z W Qiu, D D Sun, X T Ge, S M Ying, Y R Dai. [The role of S100A8/RAGE and Caveolin-1 and the effect of roxithromycin on their expression in a rat model of neutrophilic asthma]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2019 Nov; 42(11):845-851. doi: 10.3760/cma.j.issn.1001-0939.2019.11.012. [PMID: 31694095]
  • X F Gu, H J Chen, X M Chen, T T Xu, Z W Qiu, L Q Wu, W Dai, S M Ying, Y R Dai. [Expression of RAGE in asthmatic rats and the intervention of Roxithromycin]. Zhonghua yi xue za zhi. 2019 Aug; 99(32):2542-2546. doi: 10.3760/cma.j.issn.0376-2491.2019.32.015. [PMID: 31484284]
  • Syed Faheem Askari Rizvi, Saleha Tariq, Muhammad Mehdi, Ahmad Junaid Hassan. Synthesis of 99m Tc-roxithromycin: A novel diagnostic agent to discriminate between septic and aseptic inflammation. Chemical biology & drug design. 2019 06; 93(6):1166-1174. doi: 10.1111/cbdd.13412. [PMID: 30370631]
  • Yu Ke, Xiaoye Zhang, Caikun Liu, Meng Xiao, Hong Li, Jiachen Fan, Pengcheng Fu, Shuhao Wang, Fei Zan, Gang Wu. Polypseudorotaxane functionalized magnetic nanoparticles as a dual responsive carrier for roxithromycin delivery. Materials science & engineering. C, Materials for biological applications. 2019 Jun; 99(?):159-170. doi: 10.1016/j.msec.2019.01.078. [PMID: 30889688]
  • Qian Xiong, Li-Xin Hu, You-Sheng Liu, Tuan-Tuan Wang, Guang-Guo Ying. New insight into the toxic effects of chloramphenicol and roxithromycin to algae using FTIR spectroscopy. Aquatic toxicology (Amsterdam, Netherlands). 2019 Feb; 207(?):197-207. doi: 10.1016/j.aquatox.2018.12.017. [PMID: 30584953]
  • C Behr, S Sperber, X Jiang, V Strauss, H Kamp, T Walk, M Herold, K Beekmann, I M C M Rietjens, B van Ravenzwaay. Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics. Toxicology and applied pharmacology. 2018 09; 355(?):198-210. doi: 10.1016/j.taap.2018.06.028. [PMID: 30008377]
  • Giuseppe Maiolino, Giulio Ceolotto, Michele Battistel, Giulio Barbiero, Maurizio Cesari, Laurence Amar, Brasilina Caroccia, Roberto Padrini, Michel Azizi, Gian Paolo Rossi. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism. Blood pressure. 2018 08; 27(4):200-205. doi: 10.1080/08037051.2018.1436961. [PMID: 29409357]
  • Mengling Xia, Hui Xu, Wei Dai, Cong Zhu, Liqin Wu, Sunshun Yan, Xiangting Ge, Wangfeng Zhou, Cuicui Chen, Yuanrong Dai. The role of HDAC2 in cigarette smoke-induced airway inflammation in a murine model of asthma and the effect of intervention with roxithromycin. The Journal of asthma : official journal of the Association for the Care of Asthma. 2018 04; 55(4):337-344. doi: 10.1080/02770903.2017.1337788. [PMID: 28960099]
  • Zhenhua Yan, Guanghua Lu, Hongwei Sun, Binni Ma. Influence of multi-walled carbon nanotubes on the effects of roxithromycin in crucian carp (Carassius auratus) in the presence of natural organic matter. Chemosphere. 2017 Jul; 178(?):165-172. doi: 10.1016/j.chemosphere.2017.03.043. [PMID: 28324838]
  • Qing-Mei Pei, Ping Jiang, Min Yang, Xue-Jiao Qian, Jiang-Bo Liu, Sung-Ho Kim. Roxithromycin inhibits VEGF-induced human airway smooth muscle cell proliferation: Opportunities for the treatment of asthma. Experimental cell research. 2016 10; 347(2):378-84. doi: 10.1016/j.yexcr.2016.08.024. [PMID: 27587274]
  • Jie Ding, Fengshuang Zhang, Xiaopan Zhang, Long Wang, Changjia Wang, Qi Zhao, Yang Xu, Lan Ding, Nanqi Ren. Determination of roxithromycin from human plasma samples based on magnetic surface molecularly imprinted polymers followed by liquid chromatography-tandem mass spectromer. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2016 May; 1021(?):221-228. doi: 10.1016/j.jchromb.2015.08.001. [PMID: 26300321]
  • Qing Yan, Guozhong Feng, Xu Gao, Chengxiao Sun, Jin-song Guo, Zhiwei Zhu. Removal of pharmaceutically active compounds (PhACs) and toxicological response of Cyperus alternifolius exposed to PhACs in microcosm constructed wetlands. Journal of hazardous materials. 2016 Jan; 301(?):566-75. doi: 10.1016/j.jhazmat.2015.08.057. [PMID: 26465971]
  • Hanna Wosicka-Frąckowiak, Krzysztof Cal, Justyna Stefanowska, Eliza Główka, Magdalena Nowacka, Wiktoria Struck-Lewicka, Biljana Govedarica, Monika Pasikowska, Renata Dębowska, Teofil Jesionowski, Stane Srčič, Michał Jan Markuszewski. Roxithromycin-loaded lipid nanoparticles for follicular targeting. International journal of pharmaceutics. 2015 Nov; 495(2):807-15. doi: 10.1016/j.ijpharm.2015.09.068. [PMID: 26456292]
  • Inna Galvidis, Gennady Lapa, Maksim Burkin. Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes. Analytical biochemistry. 2015 01; 468(?):75-82. doi: 10.1016/j.ab.2014.09.009. [PMID: 25256165]
  • Muhammad Sirajuddin, Saqib Ali, Vickie McKee, Manzar Sohail, Hammad Pasha. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA. European journal of medicinal chemistry. 2014 Sep; 84(?):343-63. doi: 10.1016/j.ejmech.2014.07.028. [PMID: 25036793]
  • Henrik Svanström, Björn Pasternak, Anders Hviid. Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study. BMJ (Clinical research ed.). 2014 Aug; 349(?):g4930. doi: 10.1136/bmj.g4930. [PMID: 25139799]
  • Y Gong, J Lu, X Ding, Y Yu. Effect of adjunctive roxithromycin therapy on interleukin-1β, transforming growth factor-β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine A-treated patients with gingival overgrowth. Journal of periodontal research. 2014 Aug; 49(4):448-57. doi: 10.1111/jre.12123. [PMID: 23947915]
  • Sheng-Na Han, Song-Hua Yang, Yu Zhang, Yan-Yan Duan, Xiao-Yan Sun, Qiu Chen, Tian-Li Fan, Zhen-Kun Ye, Chen-Zheng Huang, Xiang-Jie Hu, Zhao Zhang, Li-Rong Zhang. Blockage of hERG current and the disruption of trafficking as induced by roxithromycin. Canadian journal of physiology and pharmacology. 2013 Dec; 91(12):1112-8. doi: 10.1139/cjpp-2012-0456. [PMID: 24289083]
  • Joo Hyun Lee, Young Ju Park, Ju-Hee Oh, Young-Joo Lee. Decrease in gastrointestinal absorption of roxithromycin in bile duct cannulated rats due to depletion of bile salts. Biopharmaceutics & drug disposition. 2013 Sep; 34(6):360-4. doi: 10.1002/bdd.1845. [PMID: 23703541]
  • Keiji Kuroda, Radha Venkatakrishnan, Madhuri S Salker, Emma S Lucas, Fozia Shaheen, Masako Kuroda, Andrew Blanks, Mark Christian, Siobhan Quenby, Jan J Brosens. Induction of 11β-HSD 1 and activation of distinct mineralocorticoid receptor- and glucocorticoid receptor-dependent gene networks in decidualizing human endometrial stromal cells. Molecular endocrinology (Baltimore, Md.). 2013 Feb; 27(2):192-202. doi: 10.1210/me.2012-1247. [PMID: 23275455]
  • Xijuan Tan, Zhenghua Song. Continuous, quantitative monitoring of roxithromycin in human saliva by flow injection chemiluminescence analysis. Applied spectroscopy. 2013 Jan; 67(1):54-8. doi: 10.1366/12-06644. [PMID: 23317671]
  • X Wang, Y F Tao, L L Huang, D M Chen, S Z Yin, A Ihsan, W Zhou, S J Su, Z L Liu, Y H Pan, Z H Yuan. Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. Journal of veterinary pharmacology and therapeutics. 2012 Jun; 35(3):282-9. doi: 10.1111/j.1365-2885.2011.01322.x. [PMID: 21749408]
  • B Jiang, J Chen, Z Ruan, H Lou, L Yu. Quantification of azithromycin in human plasma by liquid chromatography tandem mass spectrometry: application to a bioequivalence study. Arzneimittel-Forschung. 2012 May; 62(5):230-5. doi: 10.1055/s-0031-1301343. [PMID: 22344571]
  • Iram Shaifali, Uma Gupta, Syed Esam Mahmood, Jawed Ahmed. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. North American journal of medical sciences. 2012 Apr; 4(4):163-9. doi: 10.4103/1947-2714.94940. [PMID: 22536558]
  • H Fr Schröder, J L Tambosi, R F Sena, R F P M Moreira, H J José, J Pinnekamp. The removal and degradation of pharmaceutical compounds during membrane bioreactor treatment. Water science and technology : a journal of the International Association on Water Pollution Research. 2012; 65(5):833-9. doi: 10.2166/wst.2012.828. [PMID: 22339017]
  • Nahed M El-Enany, Amina Abdelal, Fathalla Belal. Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate. Chemistry Central journal. 2011 Oct; 5(?):56. doi: 10.1186/1752-153x-5-56. [PMID: 21978386]
  • Stefan Oswald, Jette Peters, Monica Venner, Werner Siegmund. LC-MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells. Journal of pharmaceutical and biomedical analysis. 2011 Apr; 55(1):194-201. doi: 10.1016/j.jpba.2011.01.019. [PMID: 21310577]
  • Sonya Kleywegt, Vince Pileggi, Paul Yang, Chunyan Hao, Xiaoming Zhao, Carline Rocks, Serei Thach, Patrick Cheung, Brian Whitehead. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency. The Science of the total environment. 2011 Mar; 409(8):1481-8. doi: 10.1016/j.scitotenv.2011.01.010. [PMID: 21315426]
  • Sarah Rebecca Porter, Guy Czaplicki, Jacques Mainil, Raphaël Guattéo, Claude Saegerman. Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. International journal of microbiology. 2011; 2011(?):248418. doi: 10.1155/2011/248418. [PMID: 22194752]
  • Jaana Kusnetsov, Liisa-Kaarina Neuvonen, Timo Korpio, Søren A Uldum, Silja Mentula, Tuula Putus, Nhu Nguyen Tran Minh, Kari-Pekka Martimo. Two Legionnaires' disease cases associated with industrial waste water treatment plants: a case report. BMC infectious diseases. 2010 Dec; 10(?):343. doi: 10.1186/1471-2334-10-343. [PMID: 21126333]
  • Kyunghee Ji, Younglim Kho, Changu Park, Dohyeon Paek, Pandong Ryu, Domyung Paek, Minyoung Kim, Pangyi Kim, Kyungho Choi. Influence of water and food consumption on inadvertent antibiotics intake among general population. Environmental research. 2010 Oct; 110(7):641-9. doi: 10.1016/j.envres.2010.06.008. [PMID: 20624619]
  • Anuruk Choemunng, Kesara Na-Bangchang. An alternative liquid chromatography-mass spectrometric method for the determination of azithromycin in human plasma and its application to pharmacokinetic study of patients with malaria. The Southeast Asian journal of tropical medicine and public health. 2010 Sep; 41(5):1048-58. doi: NULL. [PMID: 21073024]
  • H Nasser, G Dib Nehme, M-C Camoin-Schweitzer, J-L Andre. [Acute renal failure following Chlamydia pneumoniae pneumonia in a child]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 2010 Aug; 17(8):1153-5. doi: 10.1016/j.arcped.2010.05.003. [PMID: 20541377]
  • Antonio Nieto, Francesc Borrull, Eva Pocurull, Rosa Maria Marcé. Occurrence of pharmaceuticals and hormones in sewage sludge. Environmental toxicology and chemistry. 2010 Jul; 29(7):1484-9. doi: 10.1002/etc.188. [PMID: 20821597]
  • Seigo Korematsu, Kyoko Yamamoto, Tomokazu Nagakura, Hiroaki Miyahara, Naho Okazaki, Kensuke Akiyoshi, Tomoki Maeda, So-ichi Suenobu, Tatsuro Izumi. The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2010 May; 21(3):489-92. doi: 10.1111/j.1399-3038.2009.00941.x. [PMID: 20546525]
  • Heidemarie Schaar, Manfred Clara, Oliver Gans, Norbert Kreuzinger. Micropollutant removal during biological wastewater treatment and a subsequent ozonation step. Environmental pollution (Barking, Essex : 1987). 2010 May; 158(5):1399-404. doi: 10.1016/j.envpol.2009.12.038. [PMID: 20085854]
  • Christoph Ort, Michael G Lawrence, Julien Reungoat, Geoff Eaglesham, Steve Carter, Jurg Keller. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water research. 2010 Jan; 44(2):605-15. doi: 10.1016/j.watres.2009.08.002. [PMID: 19717180]
  • Li Zheng, Yongping Qin, Feng Nan, Ying Wang, Nan Xu, Maozhi Liang. [Pharmacokinetics and relative bioavailability study of roxithromycin tablet in Chinese healthy volunteers by LC-MS/MS]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi. 2009 Dec; 26(6):1315-9. doi: NULL. [PMID: 20095494]
  • Mesut Ogrendik. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Clinical therapeutics. 2009 Aug; 31(8):1754-64. doi: 10.1016/j.clinthera.2009.08.014. [PMID: 19808134]
  • Bing Li, Tong Zhang, Zhaoyi Xu, Herbert Han Ping Fang. Rapid analysis of 21 antibiotics of multiple classes in municipal wastewater using ultra performance liquid chromatography-tandem mass spectrometry. Analytica chimica acta. 2009 Jul; 645(1-2):64-72. doi: 10.1016/j.aca.2009.04.042. [PMID: 19481632]
  • Carla Maria P Ribeiro, Harry Hurd, Yichao Wu, Mary E B Martino, Lisa Jones, Brian Brighton, Richard C Boucher, Wanda K O'Neal. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PloS one. 2009 Jun; 4(6):e5806. doi: 10.1371/journal.pone.0005806. [PMID: 19503797]
  • Christian Abegglen, Adriano Joss, Christa S McArdell, Guido Fink, Michael P Schlüsener, Thomas A Ternes, Hansruedi Siegrist. The fate of selected micropollutants in a single-house MBR. Water research. 2009 Apr; 43(7):2036-46. doi: 10.1016/j.watres.2009.02.005. [PMID: 19269669]
  • Bommanna Loganathan, Malia Phillips, Holly Mowery, Tammy L Jones-Lepp. Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant. Chemosphere. 2009 Mar; 75(1):70-7. doi: 10.1016/j.chemosphere.2008.11.047. [PMID: 19121838]
  • Markus Zeitlinger, Claudia Christina Wagner, Birgit Heinisch. Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective. Clinical pharmacokinetics. 2009; 48(1):23-38. doi: 10.2165/0003088-200948010-00002. [PMID: 19071882]
  • Jong-Hyun Kim, Yang-Jin Lee, Hae-Jin Sohn, Kyoung-Ju Song, Daeho Kwon, Myung-Hee Kwon, Kyung-Il Im, Ho-Joon Shin. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri. International journal of antimicrobial agents. 2008 Nov; 32(5):411-7. doi: 10.1016/j.ijantimicag.2008.05.018. [PMID: 18762406]
  • Cheng Li, Cheul-Seol Kim, Jeong-Yeol Yang, Yeong-Jin Park, Jun-Shik Choi. Effects of roxithromycin on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats. European journal of drug metabolism and pharmacokinetics. 2008 Oct; 33(4):231-6. doi: 10.1007/bf03190877. [PMID: 19230596]
  • Farzana Latif Ansari, Fatima Iftikhar, Ihsan-Ul-Haq, Bushra Mirza, Mohammad Baseer, Umer Rashid. Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines. Bioorganic & medicinal chemistry. 2008 Aug; 16(16):7691-7. doi: 10.1016/j.bmc.2008.07.009. [PMID: 18650096]
  • Jaekyu Shin, Daniel F Pauly, Julie A Johnson, Reginald F Frye. Simplified method for determination of clarithromycin in human plasma using protein precipitation in a 96-well format and liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2008 Aug; 871(1):130-4. doi: 10.1016/j.jchromb.2008.06.050. [PMID: 18639501]
  • Chanaz Salmi, Celine Loncle, Nicolas Vidal, Yves Letourneux, Jacques Fantini, Marc Maresca, Nadira Taïeb, Jean-Marie Pagès, Jean Michel Brunel. Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?. PloS one. 2008 Jul; 3(7):e2765. doi: 10.1371/journal.pone.0002765. [PMID: 18648511]
  • Jingwu Wang, Zhiming Yang, Xiaoxia Wang, Nianjun Yang. Capillary electrophoresis with gold nanoparticles enhanced electrochemiluminescence for the detection of roxithromycin. Talanta. 2008 Jun; 76(1):85-90. doi: 10.1016/j.talanta.2008.02.006. [PMID: 18585245]
  • S A P Condé, F M Aarestrup, B J Vieira, M G Bastos. Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplantation proceedings. 2008 Jun; 40(5):1435-8. doi: 10.1016/j.transproceed.2008.04.012. [PMID: 18589124]
  • Maritza Barcia-Macay, Fatima Mouaden, Marie-Paule Mingeot-Leclercq, Paul M Tulkens, Françoise Van Bambeke. Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts). The Journal of antimicrobial chemotherapy. 2008 Jun; 61(6):1288-94. doi: 10.1093/jac/dkn120. [PMID: 18375379]
  • Constantinos Kousoulos, Georgia Tsatsou, Yannis Dotsikas, Constantinos Apostolou, Yannis L Loukas. Validation of a fully automated high throughput liquid chromatographic/tandem mass spectrometric method for roxithromycin quantification in human plasma. Application to a bioequivalence study. Biomedical chromatography : BMC. 2008 May; 22(5):494-501. doi: 10.1002/bmc.958. [PMID: 18059078]
  • J M Branley, B Roy, D E Dwyer, T C Sorrell. Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2008 Apr; 27(4):269-73. doi: 10.1007/s10096-007-0431-0. [PMID: 18183441]
  • Marta Carballa, Guido Fink, Francisco Omil, Juan M Lema, Thomas Ternes. Determination of the solid-water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. Water research. 2008 Jan; 42(1-2):287-95. doi: 10.1016/j.watres.2007.07.012. [PMID: 17675136]
  • Ines Glojnaric, Snjezana Cuzic, Vesna Erakovic-Haber, Michael J Parnham. The serum amyloid A response to sterile silver nitrate in mice and its inhibition by dexamethasone and macrolide antibiotics. International immunopharmacology. 2007 Dec; 7(12):1544-51. doi: 10.1016/j.intimp.2007.07.031. [PMID: 17920531]
  • Mohamed I Walash, Mohamed S Rizk, Manal I Eid, Mona E Fathy. Spectrophotometric determination of four macrolide antibiotics in pharmaceutical formulations and biological fluids via binary complex formation with eosin [corrected]. Journal of AOAC International. 2007 Nov; 90(6):1579-87. doi: NULL. [PMID: 18193735]
  • Norihide Nakada, Hiroyuki Shinohara, Ayako Murata, Kentaro Kiri, Satoshi Managaki, Nobuyuki Sato, Hideshige Takada. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water research. 2007 Nov; 41(19):4373-82. doi: 10.1016/j.watres.2007.06.038. [PMID: 17632207]
  • A J Watkinson, E J Murby, S D Costanzo. Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. Water research. 2007 Oct; 41(18):4164-76. doi: 10.1016/j.watres.2007.04.005. [PMID: 17524445]
  • Lingyun Chen, Feng Qin, Yuanyuan Ma, Famei Li. Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 Aug; 855(2):255-61. doi: 10.1016/j.jchromb.2007.05.016. [PMID: 17574935]
  • Tai-Jun Hang, Meng Zhang, Min Song, Jian-Ping Shen, Yin-di Zhang. Simultaneous determination and pharmacokinetic study of roxithromycin and ambroxol hydrochloride in human plasma by LC-MS/MS. Clinica chimica acta; international journal of clinical chemistry. 2007 Jul; 382(1-2):20-4. doi: 10.1016/j.cca.2007.03.015. [PMID: 17462615]
  • Franciszek K Główka, Marta Karaźniewicz-Łada. Determination of roxithromycin in human plasma by HPLC with fluorescence and UV absorbance detection: application to a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 Jun; 852(1-2):669-73. doi: 10.1016/j.jchromb.2007.02.022. [PMID: 17329175]
  • Yasuki Yasuda, Kei Kasahara, Fumiko Mizuno, Kazuyuki Nishi, Keiichi Mikasa, Eiji Kita. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. Antimicrobial agents and chemotherapy. 2007 May; 51(5):1741-52. doi: 10.1128/aac.01459-06. [PMID: 17353244]
  • Hiroshi Tamagawa, Takachika Hiroi, Tsunekazu Mizushima, Toshinori Ito, Hikaru Matsuda, Hiroshi Kiyono. Therapeutic effects of roxithromycin in interleukin-10-deficient colitis. Inflammatory bowel diseases. 2007 May; 13(5):547-56. doi: 10.1002/ibd.20093. [PMID: 17245768]
  • Eberhard Scheuch, Janina Spieker, Monica Venner, Werner Siegmund. Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 May; 850(1-2):464-70. doi: 10.1016/j.jchromb.2006.12.034. [PMID: 17267304]
  • Ting Huang, Tongling Li, Lan Yang, Xiaohong Xu, Pengcheng Zheng, Tingting Zhang, Jie Zheng, Shuye Chen. [Relative bioavailability of roxithromycin dispersive tablets in healthy volunteers]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi. 2007 Apr; 24(2):376-8. doi: NULL. [PMID: 17591264]
  • Rafael Szczepanowski, Irene Krahn, Nadine Bohn, Alfred Pühler, Andreas Schlüter. Novel macrolide resistance module carried by the IncP-1beta resistance plasmid pRSB111, isolated from a wastewater treatment plant. Antimicrobial agents and chemotherapy. 2007 Feb; 51(2):673-8. doi: 10.1128/aac.00802-06. [PMID: 17101677]
  • Sonja Eberl, Bertold Renner, Antje Neubert, Mareike Reisig, Iouri Bachmakov, Jörg König, Frank Dörje, Thomas E Mürdter, Andreas Ackermann, Harald Dormann, Karl G Gassmann, Eckhart G Hahn, Stefanie Zierhut, Kay Brune, Martin F Fromm. Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clinical pharmacokinetics. 2007; 46(12):1039-49. doi: 10.2165/00003088-200746120-00004. [PMID: 18027988]
  • Wenkui Li, Joan Rettig, Xiangyu Jiang, Diane T Francisco, Weng Naidong. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma. Biomedical chromatography : BMC. 2006 Nov; 20(11):1242-51. doi: 10.1002/bmc.691. [PMID: 16838265]
  • J-H Lim, B-K Park, H-I Yun. Pharmacokinetic/pharmacodynamic modelling of roxithromycin for the inhibitory effect of tumour necrosis factor-alpha and interleukin-6 production in dogs. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine. 2006 Oct; 53(8):394-8. doi: 10.1111/j.1439-0442.2006.00852.x. [PMID: 16970627]
  • Sharon L Ripp, Jessica B Mills, Odette A Fahmi, Kristen A Trevena, Jennifer L Liras, Tristan S Maurer, Sonia M de Morais. Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction. Drug metabolism and disposition: the biological fate of chemicals. 2006 Oct; 34(10):1742-8. doi: 10.1124/dmd.106.010132. [PMID: 16837568]
  • Nawal El-Rabbat, Hassan F Askal, Pakinaz Y Khashaba, Noha N Attia. A validated spectrofluorometric assay for the determination of certain macrolide antibiotics in pharmaceutical formulations and spiked biological fluids. Journal of AOAC International. 2006 Sep; 89(5):1276-87. doi: . [PMID: 17042176]
  • Zhenghua Song, Yanhong Liu, Xiaofeng Xie. In vitro monitoring picogram roxithromycin in human urine using flow injection chemiluminescence procedure. Current drug metabolism. 2006 May; 7(4):389-95. doi: 10.2174/138920006776873481. [PMID: 16724928]
  • Thomas M Polasek, John O Miners. Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate. European journal of clinical pharmacology. 2006 Mar; 62(3):203-8. doi: 10.1007/s00228-005-0091-x. [PMID: 16416302]
  • Evangelos J Giamarellos-Bourboulis, Anastasia Antonopoulou, Maria Raftogiannis, Pantelis Koutoukas, Thomas Tsaganos, Vassiliki Tziortzioti, Charalambos Panagou, Theodoros Adamis, Helen Giamarellou. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa. BMC infectious diseases. 2006 Feb; 6(?):31. doi: 10.1186/1471-2334-6-31. [PMID: 16504031]
  • Wei Zhang, Bingren Xiang, Yanwei Wu, Erxin Shang. Stochastic resonance is applied to quantitative analysis for weak chromatographic signal of roxithromycin in beagle dog plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Feb; 831(1-2):307-12. doi: 10.1016/j.jchromb.2005.12.014. [PMID: 16386967]
  • Mony Shuvy, Moshe Rav-Acha, Uzi Izhar, Merav Ron, Ran Nir-Paz. Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report. BMC infectious diseases. 2006 Feb; 6(?):18. doi: 10.1186/1471-2334-6-18. [PMID: 16451727]
  • Yasuyo Urasaki, Mamoru Nori, Satoshi Iwata, Takahiro Sasaki, Osamu Hosono, Hiroshi Kawasaki, Hirotoshi Tanaka, Nam H Dang, Eiji Ikeda, Chikao Morimoto. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. The Journal of rheumatology. 2005 Sep; 32(9):1765-74. doi: . [PMID: 16142877]
  • Hirofumi Tomita, Tomohiro Osanai, Tsutomu Toki, Naotaka Maeda, Reiichi Murakami, Zhaoning Chen, Hideaki Yamabe, Hiroshi Osawa, Minoru Yasujima, Ken Okumura. Roxithromycin is an inhibitor of human coronary artery smooth muscle cells proliferation: a potential ability to prevent coronary heart disease. Atherosclerosis. 2005 Sep; 182(1):87-95. doi: 10.1016/j.atherosclerosis.2005.02.007. [PMID: 16115478]
  • B Barrett, V Borek-Dohalský, P Fejt, S Vaingátová, J Huclová, B Nemec, I Jelínek. Validated HPLC-MS-MS method for determination of azithromycin in human plasma. Analytical and bioanalytical chemistry. 2005 Sep; 383(2):210-7. doi: 10.1007/s00216-005-0018-5. [PMID: 16091946]
  • Shinichi Ueno, Dai Aoki, Fumitake Kubo, Kiyokazu Hiwatashi, Kenji Matsushita, Tohru Oyama, Ikuro Maruyama, Takashi Aikou. Roxithromycin inhibits constitutive activation of nuclear factor {kappa}B by diminishing oxidative stress in a rat model of hepatocellular carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Aug; 11(15):5645-50. doi: 10.1158/1078-0432.ccr-05-0652. [PMID: 16061884]
  • María José González de la Huebra, Ursula Vincent, Guy Bordin, Adela Rosa Rodríguez. Determination of macrolide antibiotics in porcine and bovine urine by high-performance liquid chromatography coupled to coulometric detection. Analytical and bioanalytical chemistry. 2005 May; 382(2):433-9. doi: 10.1007/s00216-004-2951-0. [PMID: 15599712]
  • Jin Sun, Tianhong Zhang, Feng Qiu, Yu Liu, Jingling Tang, Haihua Huang, Zhonggui He. Impact of pharmaceutical dosage forms on the pharmacokinetics of roxithromycin in healthy human volunteers. The Journal of antimicrobial chemotherapy. 2005 May; 55(5):796-9. doi: 10.1093/jac/dki082. [PMID: 15761061]
  • Markus Ferrari, Gerald S Werner, Barbara M Richartz, Albrecht Oehme, Eberhard Straube, Hans R Figulla. Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries. Cardiovascular ultrasound. 2005 Apr; 3(?):12. doi: 10.1186/1476-7120-3-12. [PMID: 15857519]
  • Weitao Xiao, Bo Chen, Shouzhuo Yao, Zeneng Cheng. Simultaneous determination of erythromycin propionate and base in human plasma by high-performance liquid chromatography-electrospray mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2005 Mar; 817(2):153-8. doi: 10.1016/j.jchromb.2004.11.055. [PMID: 15686979]
  • Nathalie Marissal-Arvy, Pierre Mormède. Excretion of electrolytes in Brown Norway and Fischer 344 rats: effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands. Experimental physiology. 2004 Nov; 89(6):753-65. doi: 10.1113/expphysiol.2004.028621. [PMID: 15364879]
  • Pietro Vandoni, Benedetto Morelli, Liliana Lazzati, Roberto Citterio, Arnaldo Poli, Raffaela Fetiveau, Maurizio D'Urbano, Francesco Cafiero, Enrico Viganò, Stefano De Servi. Effect of a short antibiotic treatment with roxithromycin on circulating adhesion molecules after coronary stenting: a single-center pilot trial. Italian heart journal : official journal of the Italian Federation of Cardiology. 2004 Sep; 5(9):667-72. doi: . [PMID: 15568594]
  • Marta Carballa, Francisco Omil, Juan M Lema, María Llompart, Carmen García-Jares, Isaac Rodríguez, Mariano Gómez, Thomas Ternes. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water research. 2004 Jul; 38(12):2918-26. doi: 10.1016/j.watres.2004.03.029. [PMID: 15223286]
  • S Yang, K H Carlson. Solid-phase extraction-high-performance liquid chromatography-ion trap mass spectrometry for analysis of trace concentrations of macrolide antibiotics in natural and waste water matrices. Journal of chromatography. A. 2004 Jun; 1038(1-2):141-55. doi: 10.1016/j.chroma.2004.02.084. [PMID: 15233530]
  • Ali Akcay, Mehmet Kanbay, Siren Sezer, Fatma N Ozdemir. Acute renal failure and hepatotoxicity associated with roxithromycin. The Annals of pharmacotherapy. 2004 Apr; 38(4):721-2. doi: 10.1345/aph.1d421. [PMID: 14766998]
  • Mette Drasbek, Pernille K Nielsen, Kenneth Persson, Svend Birkelund, Gunna Christiansen. Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA. BMC microbiology. 2004 Feb; 4(?):7. doi: 10.1186/1471-2180-4-7. [PMID: 15018643]
  • Mario Cazzola, Maria Gabriella Matera, Francesco Blasi. Macrolide and occult infection in asthma. Current opinion in pulmonary medicine. 2004 Jan; 10(1):7-14. doi: 10.1097/00063198-200401000-00003. [PMID: 14749600]
  • Lorinczi Lilla, Székely Edit, Kiss Eva. [Detection of Mycoplasma species in urinary tract infections in children]. Bacteriologia, virusologia, parazitologia, epidemiologia (Bucharest, Romania : 1990). 2004 Jan; 49(1-2):33-6. doi: NULL. [PMID: 16752749]
  • Norifumi Ogawa, Yoko Sugawara, Yukiko Fujiwara, Takeshi Noma. Roxithromycin promotes lymphocyte apoptosis in Dermatophagoides-sensitive asthma patients. European journal of pharmacology. 2003 Aug; 474(2-3):273-81. doi: 10.1016/s0014-2999(03)01998-8. [PMID: 12921874]
  • Hajime Terao, Kazuhito Asano, Ken-ichi Kanai, Yoshiyuki Kyo, So Watanabe, Tadashi Hisamitsu, Harumi Suzaki. Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators of inflammation. 2003 Aug; 12(4):195-202. doi: 10.1080/09629350310001599620. [PMID: 14514469]
  • Dafang Zhong, Xiangguo Shi, Lu Sun, Xiaoyan Chen. Determination of three major components of bitespiramycin and their major active metabolites in rat plasma by liquid chromatography-ion trap mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2003 Jul; 791(1-2):45-53. doi: 10.1016/s1570-0232(03)00205-8. [PMID: 12798164]